These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 18945314)

  • 41. Psoriasis and its treatment with adalimumab.
    Iaconi A; Feldman SR; Balkrishnan R
    Expert Opin Biol Ther; 2010 Jan; 10(1):133-52. PubMed ID: 20078231
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acrodermatitis continua of Hallopeau successfully treated with ixekizumab: A case report.
    Battista T; Guerrasio G; De Fata Salvatores G; Peduto T; Fabbrocini G; Di Guida A
    Dermatol Ther; 2022 May; 35(5):e15383. PubMed ID: 35174591
    [No Abstract]   [Full Text] [Related]  

  • 43. Adalimumab for treatment of moderate to severe chronic plaque psoriasis of the hands and feet: efficacy and safety results from REACH, a randomized, placebo-controlled, double-blind trial.
    Leonardi C; Langley RG; Papp K; Tyring SK; Wasel N; Vender R; Unnebrink K; Gupta SR; Valdecantos WC; Bagel J
    Arch Dermatol; 2011 Apr; 147(4):429-36. PubMed ID: 21173304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful treatment of acrodermatitis continua of Hallopeau by the tumour necrosis factor-alpha inhibitor infliximab (Remicade).
    Mang R; Ruzicka T; Stege H
    Br J Dermatol; 2004 Feb; 150(2):379-80. PubMed ID: 14996123
    [No Abstract]   [Full Text] [Related]  

  • 45. [Treatment of severe psoriasis with anti-TNF-alpha-antibody and methotrexate].
    Dalaker M; Bonesrønning JH
    Tidsskr Nor Laegeforen; 2003 Apr; 123(8):1070-1. PubMed ID: 12760225
    [No Abstract]   [Full Text] [Related]  

  • 46. Adalimumab for treatment of pyoderma gangrenosum.
    Pomerantz RG; Husni ME; Mody E; Qureshi AA
    Br J Dermatol; 2007 Dec; 157(6):1274-5. PubMed ID: 17916198
    [No Abstract]   [Full Text] [Related]  

  • 47. Acrodermatitis continua of Hallopeau successfully treated with adalimumab: A case report.
    Crowley EL; Maliyar K; Rodriguez-Bolanos F; O'Toole A; Gooderham MJ
    SAGE Open Med Case Rep; 2019; 7():2050313X19829620. PubMed ID: 30800311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Successful treatment of acrodermatitis continua of Hallopeau with sequential combination of calcipotriol and tacrolimus ointments.
    Brill TJ; Elshorst-Schmidt T; Valesky EM; Kaufmann R; Thaçi D
    Dermatology; 2005; 211(4):351-5. PubMed ID: 16286746
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis.
    Revicki DA; Willian MK; Menter A; Gordon KB; Kimball AB; Leonardi CL; Langley RG; Kimel M; Okun M
    J Dermatolog Treat; 2007; 18(6):341-50. PubMed ID: 18058494
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acrodermatitis Continua of Hallopeau with Psoriatic Arthritis.
    Khosravi-Hafshejani T; Zhou Y; Dutz JP
    J Rheumatol; 2019 Apr; 46(4):437-438. PubMed ID: 30936225
    [No Abstract]   [Full Text] [Related]  

  • 51. The successful use of etanercept in combination therapy for treatment of acrodermatitis continua of hallopeau.
    Kazinski K; Joyce KM; Hodson D
    J Drugs Dermatol; 2005; 4(3):360-4. PubMed ID: 15898294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effectiveness of brodalumab in acrodermatitis continua of Hallopeau: A case report.
    Passante M; Dastoli S; Nisticò SP; Bennardo L; Patruno C
    Dermatol Ther; 2020 Jan; 33(1):e13170. PubMed ID: 31762153
    [No Abstract]   [Full Text] [Related]  

  • 53. Adalimumab treatment for SAPHO syndrome.
    Arias-Santiago S; Sanchez-Cano D; Callejas-Rubio JL; Fernández-Pugnaire MA; Ortego-Centeno N
    Acta Derm Venereol; 2010 May; 90(3):301-2. PubMed ID: 20526553
    [No Abstract]   [Full Text] [Related]  

  • 54. Etanercept and recalcitrant acrodermatitis continua of Hallopeau.
    Nikkels AF; Piérard GE
    J Drugs Dermatol; 2006 Sep; 5(8):705-6. PubMed ID: 16991229
    [No Abstract]   [Full Text] [Related]  

  • 55. A case of psoriasis verrucosa successfully treated with adalimumab.
    Maejima H; Katayama C; Watarai A; Nishiyama H; Katsuoka K
    J Drugs Dermatol; 2012 Nov; 11(11):e74-5. PubMed ID: 23135098
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extent and clinical consequences of antibody formation against adalimumab in patients with plaque psoriasis.
    Lecluse LL; Driessen RJ; Spuls PI; de Jong EM; Stapel SO; van Doorn MB; Bos JD; Wolbink GJ
    Arch Dermatol; 2010 Feb; 146(2):127-32. PubMed ID: 20157022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Misunderstandings.
    Feldman SR
    J Dermatolog Treat; 2007; 18(1):4. PubMed ID: 17365258
    [No Abstract]   [Full Text] [Related]  

  • 58. Acrodermatitis continua of Hallopeau in a patient with myelodysplastic syndrome.
    van der Kerkhof PC; Steijlen PM; Raymakers RA
    Br J Dermatol; 1996 Apr; 134(4):754-7. PubMed ID: 8733386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pustular psoriasis and acrodermatitis continua (Hallopeau) need high doses of systemic ciclosporin A.
    Korstanje MJ; Bessems PJ; Hulsmans RF; van de Staak WJ
    Dermatologica; 1989; 179(2):90-1. PubMed ID: 2792497
    [No Abstract]   [Full Text] [Related]  

  • 60. Successful etanercept therapy in therapy refractory acrodermatitis continua suppurativa Hallopeau.
    Weisshaar E; Diepgen TL
    J Dtsch Dermatol Ges; 2007 Jun; 5(6):489-92. PubMed ID: 17537042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.